Search

Yanping Wang Phones & Addresses

  • Vestavia, AL
  • North Potomac, MD
  • 3291 Homestretch Dr, Carmel, IN 46032
  • Roseburg, OR
  • Eugene, OR
  • Evanston, IL
  • Dublin, OH
  • Rockville, MD
  • Bethesda, MD
  • Blacksburg, VA

Education

School / High School: University of Kansas School of Law

Ranks

Licence: Ohio - Active Date: 2000

Specialities

Corporate Law • International Corporate Law • Corporate Contracts • Mergers, Acquisitions and Divestitures • Intellectual Property • Employment / Labor

Professional Records

Lawyers & Attorneys

Yanping Wang Photo 1

Yanping Wang - Lawyer

View page
Address:
Miller Canfield Paddock and Stone, P.L.C
(212) 704-4419 (Office)
Licenses:
Ohio - Active 2000
Education:
University of Kansas School of Law
Specialties:
Intellectual Property - 34%
Mergers / Acquisitions - 33%
Employment / Labor - 33%
Yanping Wang Photo 2

Yanping Wang - Lawyer

View page
Specialties:
Corporate Law
International Corporate Law
Corporate Contracts
Mergers, Acquisitions and Divestitures
Intellectual Property
Employment / Labor
ISLN:
915051869
Admitted:
2000
Law School:
Political Science & Law University of China, LL.B., 1991; Renmin University of China, LL.M., 1994; University of Kansas, J.D., 2000

Business Records

Name / Title
Company / Classification
Phones & Addresses
Yanping Wang
DEWEI INTERNATIONAL, INC
Yanping Wang
BEYOND LEGAL TRANSLATION LTD
Yanping Wang
GROUP MANAGEMENT SERVICES STANDARD, INC

Publications

Us Patents

Protease Cleavable Bispecific Antibodies And Uses Thereof

View page
US Patent:
20210388118, Dec 16, 2021
Filed:
Aug 27, 2021
Appl. No.:
17/458945
Inventors:
- Binjiang, CN
Yanping Wang - Frederick MD, US
Zuoxiang Xiao - Frederick MD, US
Assignee:
Zhejiang Shimai Pharmaceutical Co. Ltd. - Binjiang
International Classification:
C07K 16/46
C07K 16/28
A61P 35/00
Abstract:
The present invention provides recombinant bispecific antibodies designed to bind to a surface antigen on target cells and to an activating component on immune cells such as T cells. The bispecific antibodies comprise two polypeptide chains that contain Fv and Fab as antigen-binding fragments and a modified Fc region to facilitate heterodimer formation In one embodiment, the bispecific antibodies further comprise protease cleavage sites and/or motifs that would cause steric occlusion of the antigen binding sites so that the antibodies would be activated only in a specific environment, e.g. in the vicinity of a tumor. In another embodiment, the bispecific antibodies comprise modified sequences that confer reduced binding affinity to CDS and/or cross-reactive binding to CDS on cells from different species.
Yanping M Wang from Vestavia, AL, age ~69 Get Report